Glucocorticoid-regulated transcription factors

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 3, 2001, Pages 211-219

  Adcock, I M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

AP 1; Asthma; Glucocorticoid receptor; Leukocytes; NF B

Indexed keywords

ACYLTRANSFERASE; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HOMOSERINE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; RNA POLYMERASE; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CONFERENCE PAPER; DNA BINDING; DNA STRUCTURE; DRUG ACETYLATION; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION;

EID: 0034931702     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0283     Document Type: Conference Paper

References (76)

1. Inflammatory mediators of asthma: An update
2. Mechanisms of gene activation
3. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
4. Glucocorticoid effects on the production and actions of immune cytokines
5. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes
6. Inhibition of interleukin-5 gene expression by dexamethasone
7. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
8. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM-CSF, IL-1β, and IL-6
9. Dexamethasone inhibition of interleukin 1β production by human monocytes. Posttranscriptional mechanisms
10. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
11. Expression of interleukin 2, interferon-gamma, and the IL-2 receptor by human peripheral blood lymphocytes
12. The pharmacology of apoptosis
13. Cell cycle regulation and apoptosis
14. Multiple steps in the regulation of transcription-factor level and activity
15. Mitogen-activated protein kinase cascades as regulators of stress responses
16. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines
17. The TAFs in the HAT
18. p300/CREB-binding protein enhances the prolactin-mediated domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response
19. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling
20. Activation and localization of transcription factor, nuclear factor-κB, in asthma
21. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies
22. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5
23. The Th1/Th2 paradigm
24. New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable?
25. Control of transcription by steroid hormones
26. Glucocorticoid receptor localization in normal and asthmatic lung
27. Glucocorticoid receptors in bronchial epithelial cells in asthma
28. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system
29. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
30. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene
31. Role of TATA-element in transcription from glucocorticoid receptor-responsive model promoters
32. Immunosuppression by glucocorticoids: Inhibition of NF-κ B activity through induction of IκB synthesis
33. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
34. Glucocorticoid-mediated repression of NF-κB activity in endothelial cells does not involve induction of IκBα synthesis
35. I-kappaB alpha independent downregulation of NF-κB activity by glucocorticoid receptor
36. Effect of dexamethasone on interleukin-1β-(IL-1β)-induced nuclear factor-κB (NF-κB) and κB-dependent transcription in epithelial cells
37. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
38. Nuclear receptor/AP-1 interaction
39. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor
40. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
41. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung
42. STAT3 acts as a co-activator of glucocorticoid receptor signaling
43. Functional interactions between Stat5 and the glucocorticoid receptor
44. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells
45. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
46. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
47. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling
48. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator
49. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
50. Different histone acetylation induced by glucocorticoids and IL-1β in human epithelial cells (A549)
51. Transcriptional control. Sinful repression
52. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
53. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures
54. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNFα) translation: Glucocorticoids inhibit TNFα translation by blocking JNK/SAPK
55. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells
56. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells
57. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
58. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA
59. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
60. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: Preferential targetting of NF-κB and lack of I-κB involvement
61. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
62. DNA binding of the glucocorticoid receptor is not essential for survival
63. Steroid resistance in asthma
64. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
65. IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNFα production by human mononuclear blood cells
66. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma
67. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma
68. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes
69. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation
70. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma
71. Corticosteroid-resistant and corticosteroid-dependent asthma: Two clinical phenotypes can be associated with the same in-vitro defects in nuclear translocation and acetylation of histone H4
72. Regulation of glucocorticoid receptor expression
73. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids
74. Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection
75. Transcription factors: A new frontier in drug discovery
76. Cyclosporin A and glucocorticiods interact synergistically in T-lymphocytes: Implications for asthma therapy